Please use this identifier to cite or link to this item: http://essuir.sumdu.edu.ua/handle/123456789/75024
Or use following links to share this resource in social networks: Recommend this item
Title Osteonectin overexpression in the case of prostate cancer with intraluminal inclusions
Authors Piddubnyi, Artem Mykhailovych  
Moskalenko, Roman Andriiovych  
Radomychelski, I.-M.
Lyndin, Mykola Serhiiovych  
Sikora, Vladyslav Volodymyrovych  
Romaniuk, Anatolii Mykolaiovych  
Keywords остеонектін
остеонектин
оsteonectin
Type Conference Papers
Date of Issue 2018
URI http://essuir.sumdu.edu.ua/handle/123456789/75024
Publisher Springer
License
Citation Piddubnyi, A. Osteonectin overexpression in the case of prostate cancer with intraluminal inclusions [Текст] / A. Piddubnyi, R. Moskalenko, I.-M. Radomychelski et al. // Virchows Archiv. European Journal of Pathology. – 2018. – Vol. 473, Suppl 1. – S.45. – Pathology: Path to Precision medicine : 30th European Congress of Pathology, 8–12 September 2018, Bilbao, Spain.
Abstract Background & Objective: Osteonectin (OSN) is secreted by osteoblasts during bone formation, initiating mineralization and promoting mineral crystal formation at sites of ectopic calcification. Also OSN was found in many types of human malignant tumours. The aim is to study the OSN expression in patients with prostate cancer (PC) and the presence of intraluminal inclusions (prostatolithes and amyloid cells).
Appears in Collections: Наукові видання (МІ)

Views

Greece Greece
1
Lithuania Lithuania
1
Romania Romania
1
Singapore Singapore
1
Ukraine Ukraine
482
United Kingdom United Kingdom
484
United States United States
2027
Unknown Country Unknown Country
41
Vietnam Vietnam
1013

Downloads

Lithuania Lithuania
1
Russia Russia
1
Ukraine Ukraine
483
United Kingdom United Kingdom
1
United States United States
2026
Unknown Country Unknown Country
6
Vietnam Vietnam
1

Files

File Size Format Downloads
Piddubnyi_Osteonectin.pdf 12,11 MB Adobe PDF 2519

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.